The Journal of Practical Medicine >

2023 , Vol. 39 >Issue 24: 3210 - 3213

DOI: https://doi.org/10.3969/j.issn.1006-5725.2023.24.011

Clinical Research

Expression of programmed cell death protein 5 in cervical cancer and its relationship with lymph node metastasis

  • Guang YANG ,
  • Danfeng ZHANG ,
  • Xiaona FENG ,
  • Yan. ZHANG
Expand
  • Department of Obstetrics and Gynecology，the First Affiliated Hospital of Jiamusi University，Jiamusi 154002，China

Received date: 2023-01-09

  Online published: 2024-01-10

Fold

Abstract

Objective To explore the expression of programmed cell death protein 5 in cervical cancer and its relationship with lymph node metastasis. Methods 98 cases of cervical cancer patients admitted to our hospital were selected as the observation group， and 98 cases of cervical benign lesions were selected as the control group. The expression levels of PDCD5 in serum and lesion tissues of the two groups were compared to analyze the relationship between PDCD5 and pathological features of cervical cancer， and the diagnostic value of PDCD5 in lymph node metastasis of patients with cervical cancer was analyzed by ROC curve. Results The expression levels of PDCD5 in serum and lesion tissue of observation group were lower than those of control group （P < 0.05）. With the increase of clinical stage and pathological grade of cervical cancer， the expression of PDCD5 in serum and lesion tissue was significantly decreased （P < 0.05）. Among the 98 patients with cervical cancer， 32 had lymph node metastasis. The expression levels of PDCD5 in serum and lesion tissue of lymph node metastasis group were lower than those of non-lymph node metastasis group （P < 0.05）. ROC curve results showed that the AUCs of PDCD5 in serum and lesion tissue to predict lymph node metastasis of cervical cancer patients were 0.810 and 0.850， respectively， with no statistical significance （P > 0.05）. Conclusion The Programmed cell death protein 5 is closely related to the pathological features of patients with cervical cancer，and it has a good predictive effect on lymph node metastasis，which is worthy of further study and application.

Key words： cervical cancer; programmed cell death protein 5; clinical stage; pathological grade; lymph node metastasis

Cite this article

Guang YANG , Danfeng ZHANG , Xiaona FENG , Yan. ZHANG . Expression of programmed cell death protein 5 in cervical cancer and its relationship with lymph node metastasis[J]. The Journal of Practical Medicine, 2023 , 39(24) : 3210 -3213 . DOI: 10.3969/j.issn.1006-5725.2023.24.011

References

1 张涛红，张萌，高丽，等. 经手术治疗宫颈癌患者的临床特征研究［J］. 中国全科医学，2020，23（25）：3207-3211.
2 杨杨，梁罗娇，周琛斐，等. CAⅨ联合CD8+TIL对宫颈癌淋巴结转移的预测价值［J］. 实用医学杂志，2021，37（12）：1549-1553.
3 TAKEDA T， KOMATSU M， CHIWAKI F，et al. Upregulation of IGF2R evades lysosomal dysfunction-induced apoptosis of cervical cancer cells via transport of cathepsins［J］. Cell Death Dis， 2019， 10（12）： 876.
4 徐霄鸾，逄越，苏鹏. 细胞程序性死亡因子家族分子在细胞凋亡中的调控作用［J］. 中国生物化学与分子生物学报，2020，36（3）：244-251.
5 任安立，李靖凯，周冬冬. 程序化细胞死亡因子5对缺氧／复氧诱导的心肌细胞凋亡和自噬的影响及机制［J］. 中国病理生理杂志，2017，33（2）：251-256.
6 刘晓冬，司亚丽，洪丹妮. 程序性细胞死亡因子5在子宫内膜癌患者中的表达分析［J］. 中国性科学，2020，29（9）：23-26.
7 卢霞，许旭. SIRT1调控Nrf2信号通路对宫颈癌细胞增殖、凋亡及迁移侵袭的影响［J］. 中国计划生育和妇产科，2021，13（6）：39-44.
8 WANG J， WU Y， LI Y，et al. Guanosine monophosphate synthase upregulation mediates cervical cancer progression by inhibiting the apoptosis of cervical cancer cells via the Stat3/P53 pathway［J］. Int J Oncol，2021，58（4）：30-33.
9 李萍，王帆，魏欣. 鼻窦鳞状细胞癌组织中PRL-3和C-erbB-2和PDCD5的表达及与病理特征的关系［J］. 中国肿瘤临床与康复，2020，27（10）：1199-1202.
10 王雷，沈维高，刘艳波，等. 过表达程序性细胞死亡基因5提高脑神经胶质瘤细胞对替莫唑胺的化疗敏感性［J］.中 国肿瘤生物治疗杂志，2019，26（8）：868-875.
11 LU J， JIANG Z， CHEN Y， et al. Knockout of programmed cell death 5 （PDCD5） gene attenuates neuron injury after middle cerebral artery occlusion in mice［J］. Brain Res， 2016， 1650：152-161.
12 杨丰赫，叶菁菁，郑铭. 程序性细胞死亡分子5（PDCD5）研究进展［J］. 生理科学进展，2021，52（1）：1-6.
13 KWAK S， LEE S H， HAN E J，et al. Serine/threonine kinase 31 promotes PDCD5-mediated apoptosis in p53-dependent human colon cancer cells［J］. J Cell Physiol，2019，234（3）：2649-2658.
14 MA Z， GUO D， WANG Q，et al. Lgr5-mediated p53 Repression through PDCD5 leads to doxorubicin resistance in Hepatocellular Carcinoma［J］. Theranostics，2019，9（10）：2967-2983.
15 刘秀芬，敖洪峰，敖金平. 程序化细胞死亡分子5在乳腺癌组织中的表达及其临床意义［J］. 检验医学，2021，36（11）：1151-1158.
16 KE Y， ABOODY M S， Alturaiki W， et al. Photosynthesized gold nanoparticles from Catharanthus roseus induces caspase-mediated apoptosis in cervical cancer cells （HeLa）［J］. Artif Cells Nanomed Biotechnol，2019，47（1）：1938-1946.
17 LIN M H， YU T A， CHANG C，et al. NMR resonance assignments of the programmed cell death protein 5 （PDCD5） from Toxoplasma gondii［J］. Bio NMR Assi，2020，14（2）：277-280.
18 许学宗，刘培培，金博，等. 血清ANXA2、PDCD5及COL4A3表达水平与肺癌患者临床病理特征及肿瘤转移的相关性［J］. 热带医学杂志，2021，21（2）：205-208.
19 GAO F， ZHAO M， HUANG S，et al. Clinicopathological Significance of Decreased Expression of the Tumor Inhibitor Gene PDCD5 in Osteoclastoma［J］. Genet Test Mol Bioma，2019，23（11）：807-814.
20 ZHANG K， WANG J， ZHANG S，et al. Effects of Tumor Necrosis Factor Alpha on the Expression of Programmed Cell Death Factor 5 in Arthritis［J］. Orthop Surg，2019，11（4）：698-704.
21 PARK S Y， HONG J Y， LEE S Y，et al. Club cell-specific role of programmed cell death 5 in pulmonary fibrosis［J］. Nat Commun.，2021，12（1）：1-13.
Options
Outlines

/

〈 〉